Literature DB >> 7490476

Interferon-gamma-dependent stimulation of Fas antigen in SV40-transformed human keratinocytes: modulation of the apoptotic process by protein kinase C.

H Takahashi1, H Kobayashi, Y Hashimoto, S Matsuo, H Iizuka.   

Abstract

Fas antigen is a cell membrane protein that has been suggested to mediate apoptosis. Using SV40-transformed human keratinocytes, we investigated the Fas-antigen-dependent apoptotic process. The expression of Fas antigen mRNA was markedly induced by interferon-gamma (IFN-gamma) treatment (500 U/ml). After IFN-gamma treatment in the presence of anti-Fas monoclonal antibody, apoptosis was induced, as detected by the formation of nucleosome-sized fragments of DNA and morphologically by apoptotic cells with round homogeneous nuclear beads detected by acridine orange staining. The apoptotic SV40-transformed keratinocytes were analyzed quantitatively by enzyme-linked immunosorbent assay using antihistone and peroxidase-conjugated anti-DNA antibodies to detect cell death. The IFN-gamma- and anti-Fas antibody-dependent apoptotis was observed by 3 h, and the maximal response was observed by 12 h. The induction of apoptosis was significantly augmented by treatment with 10 ng/ml 12-o-tetradecanoyl-phorbol-13-acetate (TPA). TPA alone had no effect on either Fas antigen expression or on the apoptotic process. Other protein kinase C activators (1-oleoyl-2-acetylglycerol and mezerein) also stimulated IFN-gamma-dependent apoptosis, whereas 4-o-methyl phorbol myristate acetate, a very weak protein kinase C activator, had only a slight effect. The TPA-induced augmentation of apoptosis was inhibited by the protein kinase C inhibitor, 1-(5-isoquinoline-sulfonyl)-2-methyl piperazine dihydrochloride (H-7). However, H-7 inhibited only the TPA-induced augmentation of apoptosis; the basal IFN-gamma- and anti-Fas-dependent apoptosis remained in the presence of H-7. Northern blot analysis revealed that c-jun mRNA was induced by IFN-gamma plus anti-Fas antibody treatment as well as by TPA treatment; the addition of IFN-gamma alone to the incubation medium had no effect on the expression of c-jun mRNA. These results indicate that IFN-gamma induces a Fas-antigen-dependent apoptotic process in SV40-transformed keratinocytes and that TPA augments the process through the activation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490476     DOI: 10.1111/1523-1747.ep12326577

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.

Authors:  S A Buechner; M Wernli; T Harr; S Hahn; P Itin; P Erb
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

2.  Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line.

Authors:  G Thuret; C Chiquet; S Herrag; J-M Dumollard; D Boudard; J Bednarz; L Campos; P Gain
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

3.  Structural characterization of a dimeric complex between the short cytoplasmic domain of CEACAM1 and the pseudo tetramer of S100A10-Annexin A2 using NMR and molecular dynamics.

Authors:  Weidong Hu; Supriyo Bhattacharya; Teresa Hong; Patty Wong; Lin Li; Nagarajan Vaidehi; Markus Kalkum; John E Shively
Journal:  Biochim Biophys Acta Biomembr       Date:  2020-08-21       Impact factor: 3.747

4.  Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.

Authors:  Y Aragane; D Kulms; D Metze; G Wilkes; B Pöppelmann; T A Luger; T Schwarz
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

5.  Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.

Authors:  J Kehren; C Desvignes; M Krasteva; M T Ducluzeau; O Assossou; F Horand; M Hahne; D Kägi; D Kaiserlian; J F Nicolas
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.